Leap Therapeutics, Inc. (NASDAQ:LPTX) released significant updates regarding its recent clinical findings and corporate presentation. In a press release titled “Leap Therapeutics Reports Initial ...

Leap Therapeutics (NASDAQ:LPTX – Get Free Report) was downgraded by Baird R W from a “strong-buy” rating to a “hold” rating in a research note issued on Wednesday,Zacks.com reports. Several other ...

The most recent announcement from Laowa is not a new lens but the release of the company’s new short film, The Leap Beneath, ...

When we came upon this area, I told my husband to stop. I took a few shots, and this was my favorite,' Wendy Hampe said.

Fintel reports that on January 29, 2025, HC Wainwright & Co. downgraded their outlook for Leap Therapeutics (NasdaqCM:LPTX) ...

Last week, we looked at occurrences at Lover’s Leap from 1915 through 1938; this week we will cover from the forties to the ...

Baird downgraded Leap Therapeutics (LPTX) to Neutral from Outperform with a price target of $1.25, down from $9, after the ...

H.C. Wainwright adjusted its stance on Leap Therapeutics (NASDAQ:LPTX), downgrading the biopharmaceutical company's stock ...

San Francisco and Bengaluru-based overseas education startup Leap has secured $65 Mn (INR 562.7 Cr) as a part of its Series E ...

Overseas education company Leap has raised USD $65 million in Series E funding, bringing its total equity backing to ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Leap Therapeutics (LPTX – Research Report) ...